SAN DIEGO--(BUSINESS WIRE)--Aug. 11, 2006--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced today financial results for three months ended June 30, 2006. Aeolus reported a net loss of $3,178,000, or $0.17 per share, for the three months ended June 30, 2006, compared to a loss of $1,636,000, or $0.12 per share, for the three months ended June 30, 2005. The higher net loss for the quarter ended June 2006 principally reflects a $2.2 million charge associated with a decrease in the fair value of common stock warrants (explained below). The loss from operations during the quarter improved from $(1.6) million in the quarter ended June 2005 to $(0.9) million in the quarter ended June 2006. For the nine months ended June 30, 2006, the Company reported a net loss of $5,595,000, or $0.36 per share, compared to a loss of $5,253,000, or $0.38 per share, for the nine months ended June 30, 2005.
